Cipla Ltd.
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- Public
- Established
- 1935-01-01
- Employees
- 40.9K
- Market Cap
- -
- Website
- http://www.cipla.com
BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma
Phase 3
Not yet recruiting
- Conditions
- Bronchial Asthma
- Interventions
- First Posted Date
- 2023-12-04
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- Cipla Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT06154304
- Locations
- 🇺🇸
Velocity CLinical Research, Medford, Oregon, United States
BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient
Phase 3
Completed
- Conditions
- Asthma
- Interventions
- Drug: Symbicort, 80 Mcg-4.5 Mcg/Inh Inhalation AerosolDrug: Placebo
- First Posted Date
- 2022-04-12
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- Cipla Ltd.
- Target Recruit Count
- 1485
- Registration Number
- NCT05322707
- Locations
- 🇺🇸
Velocity Clinical Research, Medford, Oregon, United States
BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients
Phase 3
Completed
- Conditions
- Bronchial Asthma
- Interventions
- First Posted Date
- 2018-01-09
- Last Posted Date
- 2020-08-13
- Lead Sponsor
- Cipla Ltd.
- Target Recruit Count
- 1366
- Registration Number
- NCT03394989
- Locations
- 🇺🇸
Combined Research Orlando, Orlando, Florida, United States
Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
Phase 3
Completed
- Conditions
- Bronchial Asthma
- Interventions
- Drug: PlaceboDrug: 180 mcg Reference ProductDrug: 90 mcg Reference ProductDrug: 90 mcg Test Product
- First Posted Date
- 2015-12-08
- Last Posted Date
- 2019-07-25
- Lead Sponsor
- Cipla Ltd.
- Target Recruit Count
- 110
- Registration Number
- NCT02624505
- Locations
- 🇺🇸
Colorado Allergy and Asthma Centers, Denver, Colorado, United States
© Copyright 2025. All Rights Reserved by MedPath